Profil
G.
Todd Milne is the founder of Ironwood Pharmaceuticals, Inc., which was founded in 1998.
He held the title of Vice President-Biology from 2009 to 2011.
Dr. Milne also worked as a Principal at the Whitehead Institute for Biomedical Research.
Additionally, he served as the Senior Vice President-External Innovation at Cyclerion Therapeutics, Inc. from 2022 to 2023.
Dr. Milne obtained a doctorate degree from Harvard University and an undergraduate degree from Yale University.
Anciens postes connus de G. Todd Milne
| Sociétés | Poste | Fin |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2023 |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Corporate Officer/Principal | - |
| IRONWOOD PHARMACEUTICALS, INC. | Fondateur | - |
Formation de G. Todd Milne
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
















